DOTTI; Gianpietro

Patent Applications and Registrations

Patent applications and USPTO patent grants for DOTTI; Gianpietro.The latest application filed is for "highly modular biepitopic and bispecific car-t cells for cancer immunotherapy".

Company Profile

9.4.23

DOTTI; Gianpietro - Chapel Hill NC
Dotti; Gianpietro - Houston TX US
Dotti; Gianpietro - Chapell Hill NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Highly Modular Biepitopic And Bispecific Car-t Cells For Cancer Immunotherapy App 20220064326 - LIU; Rihe ; et al.	2022-03-03
Methods And Compositions For Chimeric Antigen Receptor Targeting Cancer Cells App 20210252067 - Dotti; Gianpietro ; et al.	2021-08-19
Targeting The Tumor Microenvironment Using Manipulated Nkt Cells App 20210220403 - METELITSA; Leonid S. ; et al.	2021-07-22
Targeting The Tumor Microenvironment Using Manipulated Nkt Cells App 20210106622 - METELITSA; Leonid S. ; et al.	2021-04-15
Methods And Compositions For Chimeric Antigen Receptor Targeting Cancer Cells App 20200369743 - Dotti; Gianpietro ; et al.	2020-11-26
Methods and compositions for chimeric antigen receptor targeting cancer cells Grant 10,519,214 - Dotti , et al. Dec	2019-12-31
Methods And Compositions For Chimeric Antigen Receptor Targeting Cancer Cells App 20190153063 - Dotti; Gianpietro ; et al.	2019-05-23
Methods and compositions for chimeric antigen receptor targeting cancer cells Grant 10,233,226 - Dotti , et al.	2019-03-19
Modified Cells For Immunotherapy App 20190048085 - Dotti; Gianpietro ; et al.	2019-02-14
Methods And Compositions For Chimeric Antigen Receptor Targeting Cancer Cells App 20180371053 - Dotti; Gianpietro ; et al.	2018-12-27
Csgp4 - Specific Chimeric Antigen Receptor For Cancer App 20180251568 - Dotti; Gianpietro ; et al.	2018-09-06
Survivin Specific T-cell Receptor Targeting Tumor But Not T Cells App 20170335290 - Savoldo; Barbara ; et al.	2017-11-23
Glypican-3 Specific Chimeric Antigen Receptors For Adoptive Immunotherapy App 20170281683 - Heczey; Andras ; et al.	2017-10-05
Immunotherapy Of Cancer Using Genetically Engineered Gd2-specific T Cells App 20170027988 - Brenner; Malcolm ; et al.	2017-02-02
CSGP4 - Specific Chimeric Antigen Receptor for Cancer App 20160376375 - Dotti; Gianpietro ; et al.	2016-12-29
Immunotherapy of cancer using genetically engineered GD2-specific T cells Grant 9,493,740 - Brenner , et al. November 15, 2	2016-11-15
Heparanase Expression In Human T Lymphocytes App 20160017302 - Dotti; Gianpietro ; et al.	2016-01-21
Targeting Cd138 In Cancer App 20160017048 - Dotti; Gianpietro ; et al.	2016-01-21
Targeting The Tumor Microenvironment Using Manipulated Nkt Cells App 20140255363 - Metelitsa; Leonid S. ; et al.	2014-09-11
Immunotherapy Of Cancer Using Genetically Engineered Gd2-specific T Cells App 20140004132 - Brenner; Malcolm ; et al.	2014-01-02
Engineered Cd19-specific T Lymphocytes That Coexpress Il-15 And An Inducible Caspase-9 Based Suicide Gene For The Treatment Of B-cell Malignancies App 20130071414 - Dotti; Gianpietro ; et al.	2013-03-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.